Thoracic spine pain is as disabling as neck and low back pain without receiving the same level of attention in the scientific literature. Among the different structures that can refer pain to the thoracic spine, muscles often play a relevant role. Trigger points (TrPs) from neck, shoulder and spinal muscles can induce pain in the region of the thoracic spine. There is a lack of evidence reporting the presence of TrPs in the region of the thoracic spine, but clinical evidence suggests that TrPs can be a potential source of thoracic spine pain. The current paper discusses the role of TrPs in the thoracic spine and dry needling (DN) for the management of TrPs in the thoracic multifidi and longissimus thoracis. This paper also includes a brief discussion of the application of DN in other tissues such as tendons, ligaments and scars.
Introduction
Back pain represents a major public health issue for society. Thoracic spine pain has not received as much attention as the cervical and lumbar spine in the scientific literature, yet it can be just as disabling. In fact, whereas several epidemiological studies have investigated the prevalence of neck and low back pain, there are few prevalence studies on thoracic spine pain. The prevalence of thoracic spine pain varied considerably depending on the definition criteria. Briggs et al. found that the 1-year prevalence of thoracic spine pain ranged from 3.0 to 55.0% in an adult working population. 1 In a systematic review, the same authors identified that the point prevalence for thoracic pain ranged from 4 to 72%, a 1-month prevalence from 1.4 to 34.8%, a 1-year prevalence from 3.5 to 34.8%, and a lifetime prevalence from 15.6 to 19.5%. 2 This review also reported a 1-year incidence of 3.8 to 35.3% for thoracic pain. 2 The prevalence of thoracic spine pain is higher in women than in men with a female-to-male ratio of 2:1. 3 Considering the impact of thoracic spine pain on society, determining the most appropriate treatment strategies for this area is essential, especially because having pain in the thoracic spine is a predictor of not returning to work in men. 4 Because thoracic pain can be due to several different factors, knowing the potential causes of nociception and resultant pain is of importance to ensure that a proper and thorough examination are performed. The thoracic spine is a site of musculoskeletal pain of systemic origin and patients with thoracic spine pain are more likely to have serious pathology compared to patients with lumbar or cervical pain. 5 Several visceral structures can refer to different levels of the thoracic spine, including the heart, aorta, lungs, oesophagus, stomach, duodenum, pancreas, gall bladder, liver, kidney and ureter. Several inflammatory and infectious disorders induce pain into the thoracic spine including rheumatoid arthritis, ankylosing spondylitis, osteomyelitis, Pott's disease or spinal infection. 6 Primary cancer, such as osteoid osteoma, can cause thoracic spine pain and impairments in the spinal canal and spinal nerve roots, including foraminal stenosis, arthrosis, diffuse idiopathic skeletal hyperostosis or zygapophyseal joint cysts. 7 The thoracic spine can also harbour metastases from breast cancer and other primary cancer sources, including the lungs, thyroid, oesophagus and skin. Other conditions that may contribute to thoracic spine pain include acromegaly, osteoporosis, Paget's disease and sickle cell disease. 6 Screening for potential underlying medical conditions is important to establish the proper diagnosis and develop the optimal plan of care. The paper on screening and imaging in this special issue will cover this topic in detail.
From a musculoskeletal perspective, thoracic spine pain is often thought to be due to the facet joints, because of their innervation from the medial branch of the primary dorsal rami. 8 Although facet joint pain is poorly defined in a clinical sense, the prevalence of thoracic pain from the facet joints is reported to range from 34 to 48%. 9, 10 Anaesthetic facet blocks are poorly correlated with observations based on imaging studies, e.g., MRI or CT. In addition, the effectiveness of facet joint nerve blocks is quite variable 11, 12 and it is therefore necessary to explore other potential sources of thoracic spine pain.
Muscle Pain and Thoracic Spine Myofascial trigger points (TrPs)
The International Association for the Study of Pain recognises that muscles are a common source of musculoskeletal pain, including thoracic spine pain. At the motor endplate, CGRP contributes to the up-regulation of ACh receptors, increases the release of ACh from the motor nerve terminal and inhibits AChE, which contributes to an increased quantity of ACh in the synaptic cleft, an increase in the frequency of end-plate potentials, sarcomere contraction, and taut band formation. 30 At the dorsal horn lamina, CGRP can potentiate substance P, activate second messenger pathways protein kinase A and C (PKA and PKC), and enhance the release of brain derived neurotrophic factor (BDNF), which all contribute to the experience of pain. Active and latent myofascial TrPs have altered chemical milieus as compared to normal muscle. 33, 35, 36 As described, the local biochemical changes may activate muscle nociceptors and contribute to peripheral and central sensitisation mechanisms and also to functional changes within the dorsal horn. 37 
Dry Needling (DN) Interventions for Tendons, Entheses and Scar Tissues
As early as 1979, Lewit described DN of multiple tissues in addition to targetting TrPs, including insertion points of ligaments, scar tissue, periosteum, muscle spasms, tendons, entheses and even joints. 38 He observed immediate analgesia in 271 out of 312 painful structures following DN and suggested that the intensity of the painful stimulus was crucial. In addition, patients with myofascial pain, for example, following a whiplash accident, often present with painful entheses, which can indeed be treated effectively with DN. 39 There is also evidence from the medical literature that DN of fascial tissue may be indicated for pain relief, which likely involves targetting fibroblasts. [40] [41] [42] Overall, there is limited scientific support for DN of all these structures. It is, however, a defensible position that physical therapists should incorporate elements of the acupuncture literature, 43 where needling procedures are described for a range of neuromusculoskeletal diagnoses, e.g., osteoarthritis, 44 low back pain 45 and migraine, 46 as long as the diagnoses and indications are within the scope of physical therapy practice. In the context of the current paper, we have opted to exclude the acupuncture literature and focus primarily on myofascial trigger point dry needling (TrP-DN).
Trigger Point Dry Needling
Dry needling is a 'skilled intervention that uses a thin filiform needle to penetrate the skin and stimulate underlying TrPs, muscles and connective tissues for the management of both neuro-musculoskeletal pain and movement impairments'. 47 In fact, the Physiotherapy Acupuncture Association of New Zealand separated acupuncture by physical therapist in three main categories: traditional acupuncture, western acupuncture and TrP-DN. 48 They describe DN as a rapid, shortterm needling to altered or dysfunctional tissues in order to improve or restore function. This may include (but is not limited to) needling of myofascial TrPs, periosteum and connective tissues. It may be performed with an acupuncture needle or any other injection needle without the injection of a fluid. This is a common practice utilised by both traditional and Western acupuncturists. 47 Some researchers have suggested that in patients exhibiting central sensitisation, therapeutic interventions must be pain-free to avoid increase sensitisation mechanisms, 49 which stands in direct opposition to Lewit's observations. There is emerging literature suggesting that a brief painful needle stick is insufficient to induce or maintain central sensitisation.
The response in the pain neuromatrix is strongly influenced by the context in which the painful stimulus appears and within the context of a therapeutic encounter, DN may in fact trigger a conditioned pain modulation response by activating an endogenous pain inhibitory mechanism that inhibits early nociceptive processing.
50,51
Effectiveness of TrP-DN A meta-analysis concluded that TrP-DN exhibits grade A evidence for reducing pain in upper quadrant syndrome at short-term, but given the small sample sizes of the included studies, these conclusions may be a bit premature and more research is clearly needed. 60 Another meta-analysis found no differences between TrP-DN and lidocaine immediately after treatment. 61 Looking at research detailed above and how TrP-DN influences different aspects of the musculoskeletal pain system, allows for understanding how TrP-DN in the work of Rock and Rainey had a positive effect on the reported patients. 52 Both subjects had subjective reports of pain, pain with movement and altered movement patterns. In fact, we should also consider neurophysiological mechanisms of TrP-DN. 62 
Safety of TrP-DN in the thoracic spine
Prior to performing TrP-DN of the muscles related to thoracic spine pain, there are several factors that need to be considered. First and foremost, the clinician needs to have proper training in treating this region and the musculature, as there are some risks associated with poor needling technique including penetrating the lung fields, the spinal cord, peripheral nerves or blood vessels, or causing spinal infection. [63] [64] [65] [66] There is no available evidence of reported adverse events by physical therapists performing TrP-DN in the thoracic spine and trunk region. The only study to date that has explored the safety of TrP-DN by physical therapists has reported the technique to be safe. Because there were no documented serious adverse events in 7,629 TrP-DN treatments, the risk of occurrence of a significant adverse event was calculated to be v0.04%. 67 Although TrP-DN by physical therapists is safe, it cannot be implied that there is no risk of potentially serious complication.
To optimise the safety of TrP-DN, adequate competency-based training is required. 68 Even with training, if there is any hesitation or doubt about the ability to perform TrP-DN or the known benefit of applying the technique to a particular patient, TrP-DN should not be performed, as the risk to the patient may be greater than the benefit. Finally, all healthcare providers using solid filament needles, such as physical therapists, can learn from the experiences of acupuncturists to avoid placing the safety of patients at risk.
Precautions and contraindications to TrP-DN in the thoracic spine
Precautions and contraindications specific to TrP-DN in the thoracic spine region must be addressed. Contraindications include local or systemic infections, local skin lesions in the area requiring DN or an inability to communicate appropriately. Precautions include needle aversion, severe hyperalgesia or allodynia, or abnormal bleeding tendencies. A full detailed list of precautions and contraindications are detailed within the APTA description of TrP-DN in its clinical practice resource paper. 47 An additional contraindication, not included in the APTA document, for performing TrP-DN in the thoracic spine region would be if the patient has a lipoma in the area to be treated. Lipomas can make it challenging to maintain appropriate landmarks for safety. It is not recommended that clinicians needle through a lipoma since muscles below cannot be adequately palpated. For areas other than the thoracic area, additional consideration needs to include implanted devices, pacemakers and cosmetic implants as performing TrP-DN in these areas is contraindicated.
TrP-DN of Thoracic Spine Musculature
In this section, we will discuss the application of TrP-DN into the main thoracic musculature including the thoracic multifidi and longissimus thoracis muscles.
Thoracic multifidi muscle
Trigger point dry needling of specific thoracic spine muscles requires proper knowledge of anatomy to ensure the patient's safety. 69 The thoracic multifidi have attachments from the transverse processes to the base or top of the spinous process of the vertebrae above. The deepest layers attach to the adjacent vertebrae, the most superficial layers attach three to four levels above, and those in the middle layer attach two to three levels above.
To properly palpate these muscles in the thoracic region, a finger must be placed immediately next to the spinous processes on either side. In this 'gutter or valley', TrPs in these muscles will typically feel like dense 'speed bumps' as the clinician palpates longitudinally down each level next to the spinous processes. To insert a needle safely into the thoracic multifidi muscle, there is a safe needle zone that must be adhered to, so that the needle does not puncture the lung cavity. The safe needle zone is one finger width (of the patient) immediately lateral to the spinous process, such that one side of the index finger is butting against the spinous process (Fig. 1) . The needle is inserted perpendicular to the skin immediately inside the lateral borders of the index finger. Once the needle is tapped into the subcutaneous tissue, it is directed in a caudal medial direction towards the lamina (Fig. 2) . In order to know that the multifidus muscle has been penetrated, the needle must come into contact with the vertebrae lamina. The direction of the needle should never be in a cranial medial direction as this can cause penetration of the spinal canal. Manipulation of the needle 'in and out' of the muscle should stay within the safe needle zone and maintain a caudal medial direction to ensure coming into contact with the lamina each time. For most patients, a 0.30|50 mm needle is used to ensure proper depth while also not permitting needle insertion completely up to the handle, as the needle has the potential to break at this junction. When the needle is inserted into a myofascial TrP in the thoracic multifidi, the patient will often complain of a deep aching cramp as a referred pain sensation; however, symptoms can also refer to the chest, along a rib (mimicking an intercostal neuralgia), or downward and/or outward several thoracic segments. From a clinical perspective, it has been observed that after treatment of the thoracic multifidi on both sides in areas of joint restriction, passive inter-vertebral mobility is improved. Often, if there is a restriction in forward bending, this will be improved as well.
In the upper thoracic region, down to T6 level specifically, needling of the thoracic multifidi may have an influence on semispinalis capitis, semispinalis cervicis, splenius capitis and splenius cervicis muscles since they originate from the thoracic spine. It has been shown clinically that performing TrP-DN in this area improves pain in the cervical spine region. Additionally, TrP-DN of the thoracic multifidi muscle can also influence other muscles including middle trapezius, rhomboid major, rhomboid minor, lower trapezius, latissimus dorsi and serratus posterior inferior muscles due to their attachments to their respective thoracic spinous processes. Therefore, these muscles can be influenced from a mechanical and/or a pain referral perspective. This improvement is potentially likely due to an indirect treatment of these cervical muscles, although formal research on this topic is needed.
Longissimus thoracis muscle
The longissimus thoracis muscle is immediately lateral to the thoracic multifidi on each side of the thoracic spine. It is the 'hill' muscle next to the thoracic multifidi. The muscle attaches from the tips of the transverse processes of all the thoracic vertebrae to ribs 3 or 4 through 12 between the angles and tubercles. 69 Because there are no boney landmarks to use for TrP-DN of this muscle, a different technique from the multifidus is employed. After finding the myofascial TrP by palpating perpendicular to the muscle fibres, the TrP is marked with the guide tube by gently pressing down on the myofascial TrP. The needle is then inserted perpendicular to the skin just above the myofascial TrP, while the index and middle fingers are on each side of the needle and TrP (Fig. 3) . After the needle is quickly tapped into the skin, the needle is directed at a shallow angle towards the myofascial TrP, going longitudinally along the length of the muscle. The depth of the needle can be gradually increased, but in order to maintain safety, it should not increase to more than 30-45u u angle, depending on the muscular development of the patient (Fig. 4 ). This will ensure that the needle does not penetrate the lung. In addition to the needle being directed longitudinally into the muscle, it can have a slight medial direction, but never a lateral, as a lateral direction places the point of the needle towards the lung tissue. When manipulating the needle 'in and out' of the muscle, the direction should always stay caudal or caudal medial. For most patients, a 0.30|50 mm needle is used to ensure proper depth and coverage, while also not permitting needle insertion completely up to the handle, as the needle has the potential to break at this junction. For patients with smaller musculature, a 0.30|30 mm needle is appropriate.
The presence of a scoliosis is a contraindication to TrP-DN of both the thoracic multifidi and longissimus thoracis muscles, because of the vertebral rotation, which can alter boney landmarks and no longer ensures safety of needle insertion into the targetted tissue (Fig. 5 ).
Conclusion
The current paper summarises current evidence of the relevance of muscle pain in thoracic spine pain. Several neck, shoulder and spine muscles refer pain to the thoracic spine. TrP-DN can be safely applied to the thoracic spine musculature by an experienced clinician. There is a lack of research into this area since no study has investigated the effectiveness of TrP-DN application to the thoracic spine.
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